Skip to main content

Cervical Ripening and Induction of Labor

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

HAGAR
HAGARIsrael - Tel Aviv
1 program
1
Vaginal misoprostolPhase 11 trial
Active Trials
NCT06874049Active Not Recruiting80Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2025
2026
HAGARVaginal misoprostol

Clinical Trials (1)

Total enrollment: 80 patients across 1 trials

NCT06874049HAGARVaginal misoprostol

Comparison Between Vaginal Misoprostol Gel and Oral Misoprostol Solution in Induction of Labor

Start: Feb 2025Est. completion: Sep 202580 patients
Phase 1Active Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.